Inaugural Women’s Cancer Symposium Evaluation - Friday April 5, 2019

Please score your agreement with or assessment of the following questions and statements by rating on a scale of 1 to 5, with 5 representing the highest level of satisfaction or agreement. * *

Scoring Key: 5=Strongly Agree 4=Agree 3=Neutral 2=Disagree 1=Strongly Disagree NA=Not applicable to my practice

	5	4	3	2	1	NA
The information and/or skills learned will enhance my professional competence or ability.	The information and/or skills learned will enhance my professional competence or ability. - 5	The information and/or skills learned will enhance my professional competence or ability. - 4	The information and/or skills learned will enhance my professional competence or ability. - 3	The information and/or skills learned will enhance my professional competence or ability. - 2	The information and/or skills learned will enhance my professional competence or ability. - 1	The information and/or skills learned will enhance my professional competence or ability. - NA
This activity conveyed information which will assist me in improving the health and/or treatment outcomes of of my patients.	This activity conveyed information which will assist me in improving the health and/or treatment outcomes of of my patients. - 5	This activity conveyed information which will assist me in improving the health and/or treatment outcomes of of my patients. - 4	This activity conveyed information which will assist me in improving the health and/or treatment outcomes of of my patients. - 3	This activity conveyed information which will assist me in improving the health and/or treatment outcomes of of my patients. - 2	This activity conveyed information which will assist me in improving the health and/or treatment outcomes of of my patients. - 1	This activity conveyed information which will assist me in improving the health and/or treatment outcomes of of my patients. - NA

As a result of participating in this course, to what extent do you agree that you will be better able to accomplish these objectives *

Scoring Key: 5=Strongly Agree 4=Agree 3=Neutral 2=Disagree 1=Strongly Disagree 0=Not applicable to my practice

	5	4	3	2	1	Not Applicable
Develop an individualized treatment plan in coordination with patients multi-disciplinary care team.	Develop an individualized treatment plan in coordination with patients multi-disciplinary care team. - 5	Develop an individualized treatment plan in coordination with patients multi-disciplinary care team. - 4	Develop an individualized treatment plan in coordination with patients multi-disciplinary care team. - 3	Develop an individualized treatment plan in coordination with patients multi-disciplinary care team. - 2	Develop an individualized treatment plan in coordination with patients multi-disciplinary care team. - 1	Develop an individualized treatment plan in coordination with patients multi-disciplinary care team. - Not Applicable
Review options for screening among high risk cancer populations.	Review options for screening among high risk cancer populations. - 5	Review options for screening among high risk cancer populations. - 4	Review options for screening among high risk cancer populations. - 3	Review options for screening among high risk cancer populations. - 2	Review options for screening among high risk cancer populations. - 1	Review options for screening among high risk cancer populations. - Not Applicable
Develop novel effective strategies for newly diagnosed patients.	Develop novel effective strategies for newly diagnosed patients. - 5	Develop novel effective strategies for newly diagnosed patients. - 4	Develop novel effective strategies for newly diagnosed patients. - 3	Develop novel effective strategies for newly diagnosed patients. - 2	Develop novel effective strategies for newly diagnosed patients. - 1	Develop novel effective strategies for newly diagnosed patients. - Not Applicable
Apply improved decision-making regarding treatment options for early stage disease.	Apply improved decision-making regarding treatment options for early stage disease. - 5	Apply improved decision-making regarding treatment options for early stage disease. - 4	Apply improved decision-making regarding treatment options for early stage disease. - 3	Apply improved decision-making regarding treatment options for early stage disease. - 2	Apply improved decision-making regarding treatment options for early stage disease. - 1	Apply improved decision-making regarding treatment options for early stage disease. - Not Applicable
Explain the controversy surrounding breast density.	Explain the controversy surrounding breast density. - 5	Explain the controversy surrounding breast density. - 4	Explain the controversy surrounding breast density. - 3	Explain the controversy surrounding breast density. - 2	Explain the controversy surrounding breast density. - 1	Explain the controversy surrounding breast density. - Not Applicable
Identify young adults facing diagnosis of cancer and implications of disease and treatment on fertility potential.	Identify young adults facing diagnosis of cancer and implications of disease and treatment on fertility potential. - 5	Identify young adults facing diagnosis of cancer and implications of disease and treatment on fertility potential. - 4	Identify young adults facing diagnosis of cancer and implications of disease and treatment on fertility potential. - 3	Identify young adults facing diagnosis of cancer and implications of disease and treatment on fertility potential. - 2	Identify young adults facing diagnosis of cancer and implications of disease and treatment on fertility potential. - 1	Identify young adults facing diagnosis of cancer and implications of disease and treatment on fertility potential. - Not Applicable
Describe clinical models and treatment strategies to effectively manage the wide spectrum of needs among cancer survivors.	Describe clinical models and treatment strategies to effectively manage the wide spectrum of needs among cancer survivors. - 5	Describe clinical models and treatment strategies to effectively manage the wide spectrum of needs among cancer survivors. - 4	Describe clinical models and treatment strategies to effectively manage the wide spectrum of needs among cancer survivors. - 3	Describe clinical models and treatment strategies to effectively manage the wide spectrum of needs among cancer survivors. - 2	Describe clinical models and treatment strategies to effectively manage the wide spectrum of needs among cancer survivors. - 1	Describe clinical models and treatment strategies to effectively manage the wide spectrum of needs among cancer survivors. - Not Applicable
List a few common natural products containing significant amount of phytoestrogens.	List a few common natural products containing significant amount of phytoestrogens. - 5	List a few common natural products containing significant amount of phytoestrogens. - 4	List a few common natural products containing significant amount of phytoestrogens. - 3	List a few common natural products containing significant amount of phytoestrogens. - 2	List a few common natural products containing significant amount of phytoestrogens. - 1	List a few common natural products containing significant amount of phytoestrogens. - Not Applicable
Identify strategies to minimize barriers to early referral for cancer related impairments.	Identify strategies to minimize barriers to early referral for cancer related impairments. - 5	Identify strategies to minimize barriers to early referral for cancer related impairments. - 4	Identify strategies to minimize barriers to early referral for cancer related impairments. - 3	Identify strategies to minimize barriers to early referral for cancer related impairments. - 2	Identify strategies to minimize barriers to early referral for cancer related impairments. - 1	Identify strategies to minimize barriers to early referral for cancer related impairments. - Not Applicable

How effective were the following speakers in meeting the learning objectives?

Scoring key: 5=Very effective, 4= Effective, 3= Somewhat effective, 2= Slightly effective, 1= Completely Ineffective, N/A= Not Applicable

Friday *

	5	4	3	2	1	Not Applicable
Update on the Genetics of Breast Cancer - Arelis Martis-Negron, M.D.	Update on the Genetics of Breast Cancer - Arelis Martis-Negron, M.D. - 5	Update on the Genetics of Breast Cancer - Arelis Martis-Negron, M.D. - 4	Update on the Genetics of Breast Cancer - Arelis Martis-Negron, M.D. - 3	Update on the Genetics of Breast Cancer - Arelis Martis-Negron, M.D. - 2	Update on the Genetics of Breast Cancer - Arelis Martis-Negron, M.D. - 1	Update on the Genetics of Breast Cancer - Arelis Martis-Negron, M.D. - Not Applicable
Implant-associated Lymphoma - Niloofar Nasseri-Nik, M.D.	Implant-associated Lymphoma - Niloofar Nasseri-Nik, M.D. - 5	Implant-associated Lymphoma - Niloofar Nasseri-Nik, M.D. - 4	Implant-associated Lymphoma - Niloofar Nasseri-Nik, M.D. - 3	Implant-associated Lymphoma - Niloofar Nasseri-Nik, M.D. - 2	Implant-associated Lymphoma - Niloofar Nasseri-Nik, M.D. - 1	Implant-associated Lymphoma - Niloofar Nasseri-Nik, M.D. - Not Applicable
Management of High-risk Breast Cancer Patients - Milessa L. Pilewskie, M.D.	Management of High-risk Breast Cancer Patients - Milessa L. Pilewskie, M.D. - 5	Management of High-risk Breast Cancer Patients - Milessa L. Pilewskie, M.D. - 4	Management of High-risk Breast Cancer Patients - Milessa L. Pilewskie, M.D. - 3	Management of High-risk Breast Cancer Patients - Milessa L. Pilewskie, M.D. - 2	Management of High-risk Breast Cancer Patients - Milessa L. Pilewskie, M.D. - 1	Management of High-risk Breast Cancer Patients - Milessa L. Pilewskie, M.D. - Not Applicable
Ovarian Cancer: Recent Innovations and Standards of Care - Ginger J. Gardner, M.D.	Ovarian Cancer: Recent Innovations and Standards of Care - Ginger J. Gardner, M.D. - 5	Ovarian Cancer: Recent Innovations and Standards of Care - Ginger J. Gardner, M.D. - 4	Ovarian Cancer: Recent Innovations and Standards of Care - Ginger J. Gardner, M.D. - 3	Ovarian Cancer: Recent Innovations and Standards of Care - Ginger J. Gardner, M.D. - 2	Ovarian Cancer: Recent Innovations and Standards of Care - Ginger J. Gardner, M.D. - 1	Ovarian Cancer: Recent Innovations and Standards of Care - Ginger J. Gardner, M.D. - Not Applicable
Imaging of Gynecologic Cancer Patients - Ann Podrasky, M.D.	Imaging of Gynecologic Cancer Patients - Ann Podrasky, M.D. - 5	Imaging of Gynecologic Cancer Patients - Ann Podrasky, M.D. - 4	Imaging of Gynecologic Cancer Patients - Ann Podrasky, M.D. - 3	Imaging of Gynecologic Cancer Patients - Ann Podrasky, M.D. - 2	Imaging of Gynecologic Cancer Patients - Ann Podrasky, M.D. - 1	Imaging of Gynecologic Cancer Patients - Ann Podrasky, M.D. - Not Applicable
Updates in Breast Imaging - Deepa Masrani, M.D.	Updates in Breast Imaging - Deepa Masrani, M.D. - 5	Updates in Breast Imaging - Deepa Masrani, M.D. - 4	Updates in Breast Imaging - Deepa Masrani, M.D. - 3	Updates in Breast Imaging - Deepa Masrani, M.D. - 2	Updates in Breast Imaging - Deepa Masrani, M.D. - 1	Updates in Breast Imaging - Deepa Masrani, M.D. - Not Applicable
Serous Tubal Intraepithelial Carcinoma (STIC) Tumors - Niloofar Nasseri- Nik, M.D.	Serous Tubal Intraepithelial Carcinoma (STIC) Tumors - Niloofar Nasseri- Nik, M.D. - 5	Serous Tubal Intraepithelial Carcinoma (STIC) Tumors - Niloofar Nasseri- Nik, M.D. - 4	Serous Tubal Intraepithelial Carcinoma (STIC) Tumors - Niloofar Nasseri- Nik, M.D. - 3	Serous Tubal Intraepithelial Carcinoma (STIC) Tumors - Niloofar Nasseri- Nik, M.D. - 2	Serous Tubal Intraepithelial Carcinoma (STIC) Tumors - Niloofar Nasseri- Nik, M.D. - 1	Serous Tubal Intraepithelial Carcinoma (STIC) Tumors - Niloofar Nasseri- Nik, M.D. - Not Applicable
Fertility Options for Cancer Survivors - Steven J. Ory, M.D.	Fertility Options for Cancer Survivors - Steven J. Ory, M.D. - 5	Fertility Options for Cancer Survivors - Steven J. Ory, M.D. - 4	Fertility Options for Cancer Survivors - Steven J. Ory, M.D. - 3	Fertility Options for Cancer Survivors - Steven J. Ory, M.D. - 2	Fertility Options for Cancer Survivors - Steven J. Ory, M.D. - 1	Fertility Options for Cancer Survivors - Steven J. Ory, M.D. - Not Applicable
Advancing Cancer Survivorship - M. Beatriz Currier, M.D.	Advancing Cancer Survivorship - M. Beatriz Currier, M.D. - 5	Advancing Cancer Survivorship - M. Beatriz Currier, M.D. - 4	Advancing Cancer Survivorship - M. Beatriz Currier, M.D. - 3	Advancing Cancer Survivorship - M. Beatriz Currier, M.D. - 2	Advancing Cancer Survivorship - M. Beatriz Currier, M.D. - 1	Advancing Cancer Survivorship - M. Beatriz Currier, M.D. - Not Applicable
Integrative Medicine: How It Can Help Women With Cancer - Gary E. Deng, M.D.	Integrative Medicine: How It Can Help Women With Cancer - Gary E. Deng, M.D. - 5	Integrative Medicine: How It Can Help Women With Cancer - Gary E. Deng, M.D. - 4	Integrative Medicine: How It Can Help Women With Cancer - Gary E. Deng, M.D. - 3	Integrative Medicine: How It Can Help Women With Cancer - Gary E. Deng, M.D. - 2	Integrative Medicine: How It Can Help Women With Cancer - Gary E. Deng, M.D. - 1	Integrative Medicine: How It Can Help Women With Cancer - Gary E. Deng, M.D. - Not Applicable
Proton Therapy in Breast Cancer: Rationale, Applications and Challenges - Marcio Fagundes, M.D.	Proton Therapy in Breast Cancer: Rationale, Applications and Challenges - Marcio Fagundes, M.D. - 5	Proton Therapy in Breast Cancer: Rationale, Applications and Challenges - Marcio Fagundes, M.D. - 4	Proton Therapy in Breast Cancer: Rationale, Applications and Challenges - Marcio Fagundes, M.D. - 3	Proton Therapy in Breast Cancer: Rationale, Applications and Challenges - Marcio Fagundes, M.D. - 2	Proton Therapy in Breast Cancer: Rationale, Applications and Challenges - Marcio Fagundes, M.D. - 1	Proton Therapy in Breast Cancer: Rationale, Applications and Challenges - Marcio Fagundes, M.D. - Not Applicable
New Treatments on the Horizon for Gynecologic Cancers: Update on Clinical Trials - John P. Diaz, M.D.	New Treatments on the Horizon for Gynecologic Cancers: Update on Clinical Trials - John P. Diaz, M.D. - 5	New Treatments on the Horizon for Gynecologic Cancers: Update on Clinical Trials - John P. Diaz, M.D. - 4	New Treatments on the Horizon for Gynecologic Cancers: Update on Clinical Trials - John P. Diaz, M.D. - 3	New Treatments on the Horizon for Gynecologic Cancers: Update on Clinical Trials - John P. Diaz, M.D. - 2	New Treatments on the Horizon for Gynecologic Cancers: Update on Clinical Trials - John P. Diaz, M.D. - 1	New Treatments on the Horizon for Gynecologic Cancers: Update on Clinical Trials - John P. Diaz, M.D. - Not Applicable
MRI-Guided Linear Accelerator Radiation Therapy for Gynecologic Malignancies - Allie Garcia Serra, M.D.	MRI-Guided Linear Accelerator Radiation Therapy for Gynecologic Malignancies - Allie Garcia Serra, M.D. - 5	MRI-Guided Linear Accelerator Radiation Therapy for Gynecologic Malignancies - Allie Garcia Serra, M.D. - 4	MRI-Guided Linear Accelerator Radiation Therapy for Gynecologic Malignancies - Allie Garcia Serra, M.D. - 3	MRI-Guided Linear Accelerator Radiation Therapy for Gynecologic Malignancies - Allie Garcia Serra, M.D. - 2	MRI-Guided Linear Accelerator Radiation Therapy for Gynecologic Malignancies - Allie Garcia Serra, M.D. - 1	MRI-Guided Linear Accelerator Radiation Therapy for Gynecologic Malignancies - Allie Garcia Serra, M.D. - Not Applicable
Rehabilitation of the Person with Gynecologic Cancer - Adrian Cristian, M.D.	Rehabilitation of the Person with Gynecologic Cancer - Adrian Cristian, M.D. - 5	Rehabilitation of the Person with Gynecologic Cancer - Adrian Cristian, M.D. - 4	Rehabilitation of the Person with Gynecologic Cancer - Adrian Cristian, M.D. - 3	Rehabilitation of the Person with Gynecologic Cancer - Adrian Cristian, M.D. - 2	Rehabilitation of the Person with Gynecologic Cancer - Adrian Cristian, M.D. - 1	Rehabilitation of the Person with Gynecologic Cancer - Adrian Cristian, M.D. - Not Applicable
Scar Wars: Your Cancer Didn’t Win, Neither Should Your Scar - Jill S. Waibel, M.D.	Scar Wars: Your Cancer Didn’t Win, Neither Should Your Scar - Jill S. Waibel, M.D. - 5	Scar Wars: Your Cancer Didn’t Win, Neither Should Your Scar - Jill S. Waibel, M.D. - 4	Scar Wars: Your Cancer Didn’t Win, Neither Should Your Scar - Jill S. Waibel, M.D. - 3	Scar Wars: Your Cancer Didn’t Win, Neither Should Your Scar - Jill S. Waibel, M.D. - 2	Scar Wars: Your Cancer Didn’t Win, Neither Should Your Scar - Jill S. Waibel, M.D. - 1	Scar Wars: Your Cancer Didn’t Win, Neither Should Your Scar - Jill S. Waibel, M.D. - Not Applicable

Was this course fair, balanced and without commercial bias? *

Yes

No

Participation in this learning activity has: *

	Yes	No	Not Applicable
Increased my knowledge	Increased my knowledge - Yes	Increased my knowledge - No	Increased my knowledge - Not Applicable
Enhanced my performance	Enhanced my performance - Yes	Enhanced my performance - No	Enhanced my performance - Not Applicable
Improved my competence	Improved my competence - Yes	Improved my competence - No	Improved my competence - Not Applicable
Ensured that my patients will have improved outcomes	Ensured that my patients will have improved outcomes - Yes	Ensured that my patients will have improved outcomes - No	Ensured that my patients will have improved outcomes - Not Applicable

If you checked "No,” please explain why: *

How many patients will you see in your practice who will likely be impacted by what you learned at this activity? *

1-5

6-10

Over 10

Not applicable to my practice

Is this your first time attending this symposium? *

Yes

No

How did you hear about us? *

Would you attend this symposium again next year? *

Yes

No

If you checked "No,” please tell us why: *

Would you recommend this symposium to a colleague? *

If you checked "No,” please explain why you would not recommend this course: *

What do you intend to do differently in the treatment of your patients as a result of what you learned? What new strategies will you apply in your practice of patient care? *

If you do not plan to implement any new strategies learned, please list any barriers or obstacles that might keep you from doing so.

Suggested topics and/or speakers you would like for future symposiums.

Comments

Name

You are here

Inaugural Women’s Cancer Symposium Evaluation - Friday April 5, 2019